Testimony to Congress
The testimony of NIDA Director, Nora D. Volkow, M.D., and other senior staff before congress.
Strengthening Federal Mental Health and Substance Use Disorder Programs: Opportunities, Challenges, and Emerging Issues
|
Chairwoman Murray, Ranking Member Burr, and members of the Committee, thank you for inviting the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH)...
The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances
|
Dr. Nora Volkow testifies about the importance of advancing research on fentanyl-related substances
The Federal Responses to the Drug Overdose Epidemic
|
The twin addiction and overdose crises have collided with the COVID-19 pandemic, each exacerbating the deleterious effects of the other
Hearing on Cannabis Policies for the New Decade
|
Chairwoman Eshoo, Ranking Member Burgess, and members of the Subcommittee, thank you for inviting the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH)...
Marijuana and America’s Health: Questions and Issues for Policy Makers
|
Watch the Senate Caucus on International Narcotics Control hearing Chairman Cornyn, Co-Chairwoman Feinstein and members of the Caucus on International Narcotics Control, we appreciate the opportunity to share the content...